UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2025
Commission File Number: 001-41576
ECARX Holdings Inc.
(Translation of registrant’s name into English)
12/F, Tower 2, Park Place
88 Baise Road
Xuhui District, Shanghai 200231
People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
164828.02-BEISR01A - MSW
Explanatory Note
This current report on Form 6-K, including all exhibits hereto, is incorporated by reference into the post-effective amendment No. 2 to the registration statement on Form F-1 on Form F-3 (File No. 333-271861) and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.
164828.02-BEISR01A - MSW
EXHIBIT INDEX
Exhibit No. | Description | ||||
Press Release—ECARX Highlights Q4 2024 EBITDA Breakeven, Positive EBITDA 2025 Outlook, and Global Expansion at Investor Day 2025 | |||||
164828.02-BEISR01A - MSW
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ECARX Holdings Inc.
By | /s/ Jing (Phil) Zhou | |||||||
Name | : | Jing (Phil) Zhou | ||||||
Title | : | Chief Financial Officer | ||||||
Date: March 13, 2025
164828.02-BEISR01A - MSW